Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study. Biomol Biomed. Published online March 24, 2025. doi:10.17305/bb.2025.12321